YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Successful Management of Membranoproliferative Glomerulonephritis Type I in Pregnancy

dc.authorid Reha, Erkoc/0009-0001-7230-8843
dc.authorid Kurdoglu, Zehra/0000-0001-5191-1072
dc.authorid Kurdoglu, Mertihan/0000-0002-5344-9739
dc.authorscopusid 24461835200
dc.authorscopusid 14622889300
dc.authorscopusid 24597277200
dc.authorscopusid 13105952900
dc.authorscopusid 8409430500
dc.authorwosid Kurdoglu, Zehra/A-2453-2019
dc.authorwosid Kurdoglu, Mertihan/J-5462-2017
dc.contributor.author Kurdoglu, Mertihan
dc.contributor.author Kurdoglu, Zehra
dc.contributor.author Adali, Ertan
dc.contributor.author Soyoral, Yasemin
dc.contributor.author Erkoc, Reha
dc.date.accessioned 2025-05-10T17:19:36Z
dc.date.available 2025-05-10T17:19:36Z
dc.date.issued 2010
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Kurdoglu, Mertihan; Kurdoglu, Zehra; Adali, Ertan] Yuzuncu Yil Univ, Dept Obstet & Gynecol, Sch Med, Van, Turkey; [Soyoral, Yasemin; Erkoc, Reha] Yuzuncu Yil Univ, Dept Internal Med, Sch Med, Div Nephrol, Van, Turkey en_US
dc.description Reha, Erkoc/0009-0001-7230-8843; Kurdoglu, Zehra/0000-0001-5191-1072; Kurdoglu, Mertihan/0000-0002-5344-9739 en_US
dc.description.abstract We report the successful management of a pregnancy with preexisting nephrotic syndrome due to biopsy-proven primary membranoproliferative glomerulonephritis type I. A 21-year-old Turkish woman with membranoproliferative glomerulonephritis type I was followed up by the obstetrics and gynecology, and nephrology departments of a university hospital throughout her pregnancy starting from the 25th week of gestation. Due to progression of intrauterine growth retardation and fetal distress, a cesarean section was performed in the 33rd week of gestation. Although creatinine was unchanged, proteinuria increased with relatively stable albumin levels 3 months after delivery and her treatment was adjusted accordingly. If the mother is not suffering from hypertension or renal insufficiency, specific therapy for membranoproliferative glomerulonephritis type I during pregnancy provided by a nephrologist together with regular obstetric care may allow the patient to have a viable fetus, which might be growth retarded if proteinuria is increased. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1007/s00404-009-1071-7
dc.identifier.endpage 109 en_US
dc.identifier.issn 0932-0067
dc.identifier.issn 1432-0711
dc.identifier.issue 1 en_US
dc.identifier.pmid 19357862
dc.identifier.scopus 2-s2.0-71449101227
dc.identifier.scopusquality Q2
dc.identifier.startpage 105 en_US
dc.identifier.uri https://doi.org/10.1007/s00404-009-1071-7
dc.identifier.uri https://hdl.handle.net/20.500.14720/9854
dc.identifier.volume 281 en_US
dc.identifier.wos WOS:000272017600020
dc.identifier.wosquality Q3
dc.language.iso en en_US
dc.publisher Springer Heidelberg en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Membranoproliferative Glomerulonephritis Type I en_US
dc.subject Pregnancy en_US
dc.subject Management en_US
dc.subject Nephrotic Syndrome en_US
dc.title Successful Management of Membranoproliferative Glomerulonephritis Type I in Pregnancy en_US
dc.type Article en_US

Files